Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
Completed · Phase 2 · Has a placebo group
Conditions studied: Current or Recent History of Atrial Fibrillation
In brief
This study is being done to compare the effects of bucindolol hydrochloride (bucindolol) to metoprolol succinate (Toprol-XL) on the recurrence of symptomatic atrial fibrillation/atrial flutter in patients with heart failure who have a specific genotype for the beta-1 adrenergic receptor.
Key facts
- Study ID
- NCT01970501
- Run by
- ARCA Biopharma, Inc.
- People needed
- 267
- Starts
- 2014-04-01
- Expected to finish
- 2017-12-28
- Last updated by the study team
- 2022-09-26
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- ARCA Clinical Research Site #383 — Phoenix, Arizona, United States
- ARCA Clinical Research Site #385 — Phoenix, Arizona, United States
- ARCA Clinical Research Site #381 — East Palo Alto, California, United States
- ARCA Clinical Research Site #186 — Loma Linda, California, United States
- ARCA Clinical Research Site #320 — Pasadena, California, United States
- ARCA Clinical Research Site #390 — Stanford, California, United States
- ARCA Clinical Research Site #153 — Aurora, Colorado, United States
- ARCA Clinical Research Site #380 — Denver, Colorado, United States
- ARCA Clinical Research Site #195 — Miami, Florida, United States
- ARCA Clinical Research Site #184 — Tampa, Florida, United States
- ARCA Clinical Research Site #351 — Athens, Georgia, United States
- ARCA Clinical Research Site #389 — Atlanta, Georgia, United States
- ARCA Clinical Research Site #342 — Oakbrook Terrace, Illinois, United States
- ARCA Clinical Research Site #303 — Hammond, Indiana, United States
- ARCA Clinical Research Site #388 — Iowa City, Iowa, United States
- ARCA Clinical Site #396 — New Orleans, Louisiana, United States
- ARCA Clinical Research Site #398 — Baltimore, Maryland, United States
- ARCA Clinical Research Site #127 — Ypsilanti, Michigan, United States
- ARCA Clinical Research Site #156 — Minneapolis, Minnesota, United States
- ARCA Clinical Research Site #174 — Saint Paul, Minnesota, United States
- ARCA Clinical Research Site #108 — St Louis, Missouri, United States
- ARCA Clinical Research Site #201 — St Louis, Missouri, United States
- ARCA Clinical Research Site #152 — Lincoln, Nebraska, United States
- ARCA Clinical Research Site #161 — Elmer, New Jersey, United States
- ARCA Clinical Research Site #157 — Anchorage, Alaska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.